Latest news
InSilico Medicine Cayman TopCo (SEHK:3696) Stock May Be Below Fair Value On FDA Fast Track News - Yahoo! Finance CanadaYahoo! Finance Canada · Tue, 04 Aug 2026 02:08:00 GMTInSilico Medicine Cayman TopCo Receives NMPA IND Approval for ISM8969/HT-001, Blood-Brain-Barrier-Penetrant NLRP3 Inhibitor Co-Developed with Hygtia Therapeutics Co., Ltd - marketscreener.commarketscreener.com · Mon, 03 Aug 2026 05:21:39 GMTEnterprise value to EBIT forward of InSilico Medicine Cayman TopCo – HKEX:3696 - tradingview.comtradingview.com · Sat, 01 Aug 2026 05:36:49 GMTInsilico Medicine Launches the Industry's First Drug Discovery and Development (DDD) Benchmark as a Service, to Evaluate Frontier AI and Foundation Models on Real-World Science - marketscreener.commarketscreener.com · Thu, 30 Jul 2026 07:00:00 GMT